Concepts (98)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pemphigus, Benign Familial | 2 | 2018 | 11 | 1.190 |
Why?
|
| Retroviridae | 2 | 2018 | 196 | 0.740 |
Why?
|
| Tumor Virus Infections | 2 | 2018 | 134 | 0.720 |
Why?
|
| Lymphangioma | 1 | 2019 | 24 | 0.620 |
Why?
|
| Blister | 1 | 2019 | 22 | 0.620 |
Why?
|
| Merkel cell polyomavirus | 1 | 2018 | 3 | 0.620 |
Why?
|
| Calcineurin Inhibitors | 1 | 2018 | 29 | 0.600 |
Why?
|
| Papillomaviridae | 1 | 2018 | 145 | 0.570 |
Why?
|
| Skin Neoplasms | 3 | 2018 | 860 | 0.540 |
Why?
|
| Psoriasis | 3 | 2019 | 46 | 0.450 |
Why?
|
| Autoantibodies | 2 | 2019 | 433 | 0.260 |
Why?
|
| Diagnosis, Differential | 3 | 2019 | 1896 | 0.230 |
Why?
|
| Education, Medical, Continuing | 2 | 2018 | 141 | 0.180 |
Why?
|
| Islet Amyloid Polypeptide | 1 | 2020 | 11 | 0.170 |
Why?
|
| Primary Prevention | 2 | 2018 | 172 | 0.170 |
Why?
|
| Herpesvirus 3, Human | 1 | 2020 | 26 | 0.170 |
Why?
|
| Herpes Zoster | 1 | 2020 | 23 | 0.170 |
Why?
|
| Protein Aggregation, Pathological | 1 | 2020 | 27 | 0.170 |
Why?
|
| Gliadin | 1 | 2019 | 5 | 0.170 |
Why?
|
| ADAMTS Proteins | 1 | 2019 | 9 | 0.160 |
Why?
|
| Epigenomics | 1 | 2020 | 176 | 0.160 |
Why?
|
| Lasers, Gas | 1 | 2019 | 7 | 0.160 |
Why?
|
| Mastocytosis, Cutaneous | 1 | 2019 | 4 | 0.160 |
Why?
|
| Autoantigens | 1 | 2019 | 118 | 0.160 |
Why?
|
| Skin Diseases, Infectious | 1 | 2019 | 24 | 0.160 |
Why?
|
| Low-Level Light Therapy | 1 | 2019 | 15 | 0.160 |
Why?
|
| Deltaretrovirus | 1 | 2018 | 5 | 0.160 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2019 | 38 | 0.160 |
Why?
|
| Staphylococcal Skin Infections | 1 | 2019 | 40 | 0.150 |
Why?
|
| Arthritis, Psoriatic | 1 | 2019 | 18 | 0.150 |
Why?
|
| Anti-Allergic Agents | 1 | 2019 | 27 | 0.150 |
Why?
|
| Omalizumab | 1 | 2019 | 33 | 0.150 |
Why?
|
| Thorax | 1 | 2019 | 73 | 0.150 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-3 | 1 | 2018 | 7 | 0.150 |
Why?
|
| Amyloid beta-Peptides | 1 | 2020 | 212 | 0.150 |
Why?
|
| Herpesviridae | 1 | 2018 | 33 | 0.150 |
Why?
|
| Triamcinolone | 1 | 2018 | 13 | 0.150 |
Why?
|
| Survival Analysis | 2 | 2018 | 1496 | 0.150 |
Why?
|
| Clindamycin | 1 | 2018 | 40 | 0.150 |
Why?
|
| Axilla | 1 | 2018 | 39 | 0.150 |
Why?
|
| Administration, Cutaneous | 1 | 2018 | 66 | 0.150 |
Why?
|
| Biopsy, Needle | 1 | 2018 | 228 | 0.150 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2020 | 165 | 0.140 |
Why?
|
| Carcinoma, Merkel Cell | 1 | 2018 | 13 | 0.140 |
Why?
|
| Skin Ulcer | 1 | 2018 | 32 | 0.140 |
Why?
|
| Neck | 1 | 2018 | 135 | 0.140 |
Why?
|
| Exanthema | 1 | 2018 | 71 | 0.140 |
Why?
|
| Neoplasm Invasiveness | 1 | 2018 | 625 | 0.130 |
Why?
|
| Immunoglobulin G | 1 | 2019 | 780 | 0.130 |
Why?
|
| Biomarkers | 3 | 2020 | 3106 | 0.130 |
Why?
|
| Peptide Fragments | 1 | 2020 | 781 | 0.130 |
Why?
|
| Proteomics | 1 | 2019 | 506 | 0.130 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2018 | 319 | 0.120 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2018 | 292 | 0.120 |
Why?
|
| Prognosis | 3 | 2020 | 4685 | 0.120 |
Why?
|
| Epigenesis, Genetic | 1 | 2020 | 703 | 0.120 |
Why?
|
| Immunohistochemistry | 1 | 2018 | 1704 | 0.120 |
Why?
|
| Drug Therapy, Combination | 1 | 2018 | 1158 | 0.110 |
Why?
|
| Male | 8 | 2020 | 61529 | 0.110 |
Why?
|
| Humans | 12 | 2020 | 125298 | 0.100 |
Why?
|
| Case-Control Studies | 4 | 2020 | 3314 | 0.100 |
Why?
|
| Risk Assessment | 2 | 2018 | 3431 | 0.100 |
Why?
|
| Middle Aged | 6 | 2020 | 26725 | 0.090 |
Why?
|
| Female | 8 | 2020 | 66789 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 2429 | 0.060 |
Why?
|
| Young Adult | 1 | 2019 | 9063 | 0.060 |
Why?
|
| Combined Modality Therapy | 2 | 2018 | 1238 | 0.060 |
Why?
|
| Adult | 5 | 2020 | 29511 | 0.050 |
Why?
|
| Oncogene Proteins, Viral | 1 | 2020 | 58 | 0.040 |
Why?
|
| Protein Aggregates | 1 | 2020 | 30 | 0.040 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2020 | 85 | 0.040 |
Why?
|
| Cathelicidins | 1 | 2019 | 13 | 0.040 |
Why?
|
| Hepatitis Viruses | 1 | 2018 | 3 | 0.040 |
Why?
|
| CpG Islands | 1 | 2020 | 330 | 0.040 |
Why?
|
| Pruritus | 1 | 2019 | 41 | 0.040 |
Why?
|
| Injections, Subcutaneous | 1 | 2019 | 130 | 0.040 |
Why?
|
| Immunoglobulin E | 1 | 2019 | 162 | 0.040 |
Why?
|
| Host-Pathogen Interactions | 1 | 2020 | 253 | 0.040 |
Why?
|
| Alcohol Drinking | 1 | 2020 | 344 | 0.040 |
Why?
|
| Sentinel Lymph Node Biopsy | 1 | 2018 | 65 | 0.040 |
Why?
|
| Fingers | 1 | 2018 | 65 | 0.040 |
Why?
|
| Muscle Proteins | 1 | 2020 | 414 | 0.030 |
Why?
|
| ROC Curve | 1 | 2018 | 572 | 0.030 |
Why?
|
| Papillomavirus Infections | 1 | 2020 | 296 | 0.030 |
Why?
|
| Herpesvirus 4, Human | 1 | 2018 | 674 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 2020 | 827 | 0.030 |
Why?
|
| Gene Expression | 1 | 2020 | 1554 | 0.030 |
Why?
|
| Survival Rate | 1 | 2020 | 2051 | 0.030 |
Why?
|
| Proteins | 1 | 2020 | 1039 | 0.030 |
Why?
|
| Smoking | 1 | 2020 | 1049 | 0.030 |
Why?
|
| Biopsy | 1 | 2018 | 1244 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2020 | 1052 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2020 | 4828 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 2907 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 6555 | 0.020 |
Why?
|
| Risk Factors | 1 | 2020 | 10295 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2019 | 12280 | 0.010 |
Why?
|
| Aged | 1 | 2020 | 19702 | 0.010 |
Why?
|